Clinical Trial

The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to clarify the role of the bacterium Cutibacterium acnes in the development of degenerative disc disease in patients with lumbar disc herniation who underwent microdiscectomy as part of their regular medical care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-17.
Status change: Active, Not Recruiting → Recruiting 2025-08-26
Trial Details
NCT Number NCT07085247
Lead Sponsor Masaryk University
Collaborators: St. Anne's University Hospital Brno, Czech Republic
Conditions Lumbar Disc Herniation, Lumbar Disc Degeneration, Cutibacterium Acnes, Low Back Pain
Enrollment 400 participants
Start Date 2025-06-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-27